Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


03 julio 2013

Las cintas para correr en casa podrían ayudar a las personas con mala circulación en las piernas

Health Day News

Un programa de ejercicio con una cinta para correr en casa mejoró la velocidad y la resistencia al caminar en personas con mala circulación en las piernas, una afección conocida como enfermedad arterial periférica (EAP). Ese es el hallazgo de un estudio que incluyó a casi 200 pacientes de EAP cuyo cambio en el rendimiento en una caminata de seis minutos se midió en un periodo de seis meses.

08 julio 2013

Terumo Begins Commercial Distribution of BSDs MicroThermX(R) Microwave Ablation System at ECIO Following Successful Training of Sales Personnel

Healthcare Sales & Marketing Network

BSD Medical Corporation (BSDM) (the Company or BSD) reports completion of intensive training of Terumo sales personnel in preparation for the commercial launch by Terumo Europe NV (Terumo) of BSDs MicroThermX® Microwave Ablation System (MicroThermX) at the European Conference on Interventional Oncology (ECIO). BSD and Terumo conducted successful training of 80 Terumo sales personnel prior to the commercial launch. The increasing role of microwave ablation and MicroThermX were featured at ECIO. Terumo and BSD co-sponsored an educational symposium and workshops highlighting the MicroThermX, which were well attended and led to many potential customer contacts. ECIO is a comprehensive international meeting focused exclusively on the rapidly growing field of interventional oncology, a key market for BSDs microwave ablation products. Leading interventional oncology experts from over 60 countries attended the conference.

02 julio 2013

Despertar a los pacientes hospitalizados para revisar sus signos vitales podría hacer más daño que bien

Health Day News

La salud y el bienestar de muchos pacientes de hospital podrían mejorar si las enfermeras dejaran de realizar los chequeos nocturnos de los signos vitales, según una investigación reciente. Casi la mitad de los pacientes a quienes se despierta para realizar chequeos de los signos vitales tienen unas probabilidades extremadamente bajas de sufrir una emergencia médica dentro de las 24 horas siguientes, señaló la autora del estudio, la Dra. Dana Edelson, médico de asistencia hospitalaria del departamento de medicina de la Universidad de Chicago.

27 junio 2013

AngioDynamics Announces FDA Clearance for Xcela Plus Port Family With PASV Technology

Healthcare Sales & Marketing Network

AngioDynamics (ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced it has received two key port product clearances. The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Xcela Plus Port family, with Pressure Activated Safety Valve (PASV) technology to Navilyst Medical, an AngioDynamics company. Additionally, AngioDynamics has received the Medical Device License from Health Canada to market and sell the Smart Port CT family of power-injectable ports, featuring Vortex port technology.

01 julio 2013

Covidien Completes Separation of Pharmaceuticals Business

Healthcare Sales & Marketing Network

Covidien (COV), a leading global provider of healthcare products, today announced it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin “regular way” trading on the New York Stock Exchange today under the symbol "MNK."

16 julio 2013

Interventional radiology gains subspecialty status in Canada

Interventional News

Recognising interventional radiology as a subspecialty of radiology formally acknowledges the discipline’s importance, increases the field’s credibility, strengthens the voice of interventional radiology and improves support for the field.

29 mayo 2013

Significant And Sustained Blood Pressure Reduction With Vessix™ Renal Denervation System

Med Latest

Boston Scientific Vessix RDN deviceBoston Scientific Corporation took the opportunity presented by EuroPCR congress in Paris last week, to report interim data from its renal denervation study, tagged the REDUCE-HTN clinical program. Patients treated with the Vessix™ Renal Denervation System showed a significant and sustained reduction in the blood pressure.

10 junio 2013

Teleflex Receives FDA Clearance for ARROW NextStep Retrograde Femoral Length Dialysis Catheters

Healthcare Sales & Marketing Network

Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW® NextStep® Retrograde Femoral Length Dialysis Catheters. Designed for clinician ease of insertion and sustained high flow rates, the ARROW NextStep Retrograde Femoral Length Catheters further strengthen the NextStep Hemodialysis Catheter portfolio.

04 junio 2013

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

Healthcare Sales & Marketing Network

St. Jude Medical, Inc. (STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using the EnligHTN™ Multi-Electrode Renal Denervation System to treat patients with drug-resistant high blood pressure.

30 mayo 2013

SIR-Spheres(R) microspheres as Effective and Safe in the Elderly as they are in Younger Patients with Colorectal Liver Metastases According to Data Released at ASCO Annual Meeting

Healthcare Sales & Marketing Network

Results from the first, large multi-center study evaluating Selective Internal Radiation Therapy (SIRT) with SIR-Spheres® microspheres in patients ages 70 years and older were released today at the American Society of Clinical Oncology (ASCO) Annual Meeting. According to investigators, the use of SIR-Spheres microspheres in elderly patients with unresectable colorectal liver metastases (mCRC) appears to be as effective and well-tolerated as in younger patients.1 The findings were released by lead investigator of the MORE study, Andrew S. Kennedy, M.D., F.A.C.R.O., Director, Radiation Oncology Research at the Sarah Cannon Research Institute, Nashville, Tenn.

03 junio 2013

Anti-smoking medication shows promise for treating alcohol dependence

NIH

A smoking-cessation medication may be a viable option for the treatment of alcohol dependence, according to a study by scientists at the National Institutes of Health. The study found that varenicline (marketed under the name Chantix), approved in 2006 to help people stop smoking, significantly reduced alcohol consumption and craving among people who are alcohol-dependent. The findings were published online in the Journal of Addiction Medicine.

05 junio 2013

Asocian la dieta vegetariana con una reducción de la mortalidad en el tiempo

Reuters Health

Quienes reducen la cantidad de carne que ingieren y prefieren las frutas y las verduras son menos propensos a morir en cualquier período evaluado, según un nuevo estudio. "Esto se suma a las pruebas de los potenciales beneficios de la alimentación vegetariana para la prevención de las enfermedades crónicas y la promoción de la longevidad", dijo el autor principal del estudio, doctor Michael Orlich, de Loma Linda University, California.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.